HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Janke, J. Articles by Jordan, J. Search for Related Content PubMed PubMed Citation Articles by Janke, J. Articles by Jordan, J. Social Bookmarking                What's this?

Retinol-Binding Protein 4 in Human Obesity

¹ Franz-Volhard Clinical Research Center, Charité Campus Buch, and HELIOS Klinikum Berlin, Berlin, Germany
² Department of Medicine, McMaster University, Hamilton, Ontario, Canada

Address correspondence and reprint requests to Stefan Engeli, MD, Franz Volhard Clinical Research Center (Haus 129), Charité Campus Buch, Wiltbergstr. 50, 13125 Berlin, Germany. E-mail: stefan.engeli{at}charite.de

Abbreviations: ELISA, enzyme-linked immunosorbent assay; HOMA, homeostasis model assessment; RBP4, retinol-binding protein 4

Studies in mice suggest that adipocytes serve as glucose sensors and regulate systemic glucose metabolism through release of serum retinol-binding protein 4 (RBP4). This model has not been validated in humans. RBP4 was highly expressed in isolated mature human adipocytes and secreted by differentiating human adipocytes. In contrast to the animal data, RBP4 mRNA was downregulated in subcutaneous adipose tissue of obese women, and circulating RBP4 concentrations were similar in normal weight, overweight, and obese women (n = 74). RBP4 was positively correlated with GLUT4 expression in adipose tissue, independent of any obesity-associated variable. Five percent weight loss slightly decreased adipose RBP4 expression but did not influence circulating RBP4. In another set of experiments, we stratified patients (n = 14) by low or high basal fasting interstitial glucose concentrations, as determined by the microdialysis technique. Venous glucose concentrations were similar throughout oral glucose tolerance testing, and basal RBP4 expression in adipose tissue and serum RBP4 concentrations were similar in the groups with higher and lower interstitial glucose levels. Our findings point to profound differences between rodents and humans in the regulation of adipose or circulating RBP4 and challenge the notion that glucose uptake by adipocytes has a dominant role in the regulation of RBP4.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. M. Fernandez-Real, J. M. Moreno, and W. Ricart Circulating Retinol-Binding Protein-4 Concentration Might Reflect Insulin Resistance-Associated Iron Overload Diabetes, July 1, 2008; 57(7): 1918 - 1925. [Abstract] [Full Text] [PDF]

				J. Shea, E. Randell, S. Vasdev, P. P. Wang, B. Roebothan, and G. Sun Serum retinol-binding protein 4 concentrations in response to short-term overfeeding in normal-weight, overweight, and obese men Am. J. Clinical Nutrition, November 1, 2007; 86(5): 1310 - 1315. [Abstract] [Full Text] [PDF]

				A. Ost, A. Danielsson, M. Liden, U. Eriksson, F. H. Nystrom, and P. Stralfors Retinol-binding protein-4 attenuates insulin-induced phosphorylation of IRS1 and ERK1/2 in primary human adipocytes FASEB J, November 1, 2007; 21(13): 3696 - 3704. [Abstract] [Full Text] [PDF]

				M. Ziegelmeier, A. Bachmann, J. Seeger, U. Lossner, J. Kratzsch, M. Bluher, M. Stumvoll, and M. Fasshauer Serum Levels of Adipokine Retinol-Binding Protein-4 in Relation to Renal Function Diabetes Care, October 1, 2007; 30(10): 2588 - 2592. [Abstract] [Full Text] [PDF]

				S. Hahn, M. Backhaus, M. Broecker-Preuss, S. Tan, T. Dietz, R. Kimmig, M. Schmidt, K. Mann, and O. E Janssen Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism Eur. J. Endocrinol., August 1, 2007; 157(2): 201 - 207. [Abstract] [Full Text] [PDF]

				W. Jia, H. Wu, Y. Bao, C. Wang, J. Lu, J. Zhu, and K. Xiang Association of Serum Retinol-Binding Protein 4 and Visceral Adiposity in Chinese Subjects with and without Type 2 Diabetes J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3224 - 3229. [Abstract] [Full Text] [PDF]

				P. G. McTernan and S. Kumar Retinol Binding Protein 4 and Pathogenesis of Diabetes J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2430 - 2432. [Full Text] [PDF]

				B. K. Tan, J. Chen, H. Lehnert, R. Kennedy, and H. S. Randeva Raised Serum, Adipocyte, and Adipose Tissue Retinol-Binding Protein 4 in Overweight Women with Polycystic Ovary Syndrome: Effects of Gonadal and Adrenal Steroids J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2764 - 2772. [Abstract] [Full Text] [PDF]

				A. Yao-Borengasser, V. Varma, A. M. Bodles, N. Rasouli, B. Phanavanh, M.-J. Lee, T. Starks, L. M. Kern, H. J. Spencer III, A. A. Rashidi, et al. Retinol Binding Protein 4 Expression in Humans: Relationship to Insulin Resistance, Inflammation, and Response to Pioglitazone J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2590 - 2597. [Abstract] [Full Text] [PDF]

				M. Broch, J. Vendrell, W. Ricart, C. Richart, and J.-M. Fernandez-Real Circulating Retinol-Binding Protein-4, Insulin Sensitivity, Insulin Secretion, and Insulin Disposition Index in Obese and Nonobese Subjects Diabetes Care, July 1, 2007; 30(7): 1802 - 1806. [Abstract] [Full Text] [PDF]

				M. Qatanani and M. A. Lazar Mechanisms of obesity-associated insulin resistance: many choices on the menu Genes & Dev., June 15, 2007; 21(12): 1443 - 1455. [Abstract] [Full Text] [PDF]

				M. Vitkova, E. Klimcakova, M. Kovacikova, C. Valle, C. Moro, J. Polak, J. Hanacek, F. Capel, N. Viguerie, B. Richterova, et al. Plasma Levels and Adipose Tissue Messenger Ribonucleic Acid Expression of Retinol-Binding Protein 4 Are Reduced during Calorie Restriction in Obese Subjects but Are Not Related to Diet-Induced Changes in Insulin Sensitivity J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2330 - 2335. [Abstract] [Full Text] [PDF]

				S. Gavi, L. M. Stuart, P. Kelly, M. M. Melendez, D. C. Mynarcik, M. C. Gelato, and M. A. McNurlan Retinol-Binding Protein 4 Is Associated with Insulin Resistance and Body Fat Distribution in Nonobese Subjects without Type 2 Diabetes J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1886 - 1890. [Abstract] [Full Text] [PDF]

				P. Balagopal, T. E. Graham, B. B. Kahn, A. Altomare, V. Funanage, and D. George Reduction of Elevated Serum Retinol Binding Protein in Obese Children by Lifestyle Intervention: Association with Subclinical Inflammation J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1971 - 1974. [Abstract] [Full Text] [PDF]

				N. Stefan, A. M. Hennige, H. Staiger, J. Machann, F. Schick, E. Schleicher, A. Fritsche, and H.-U. Haring High Circulating Retinol-Binding Protein 4 Is Associated With Elevated Liver Fat but Not With Total, Subcutaneous, Visceral, or Intramyocellular Fat in Humans Diabetes Care, May 1, 2007; 30(5): 1173 - 1178. [Abstract] [Full Text] [PDF]

				Y. M. Cho, B.-S. Youn, and K. S. Park Plasma Retinol-Binding Protein-4 Concentrations Are Elevated in Human Subjects With Impaired Glucose Tolerance and Type 2 Diabetes: Response to Gavi et al. Diabetes Care, March 1, 2007; 30(3): e8 - e8. [Full Text] [PDF]

				D. G. Haider, K. Schindler, G. Prager, A. Bohdjalian, A. Luger, M. Wolzt, and B. Ludvik Serum Retinol-Binding Protein 4 Is Reduced after Weight Loss in Morbidly Obese Subjects J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 1168 - 1171. [Abstract] [Full Text] [PDF]

				R. M. van Dam and F. B. Hu Lipocalins and Insulin Resistance: Etiological Role of Retinol-Binding Protein 4 and Lipocalin-2? Clin. Chem., January 1, 2007; 53(1): 5 - 7. [Full Text] [PDF]